Oct 26 (Reuters) - SciVac Therapeutics Inc VAC.TO :
* Enters into agreement to acquire VBI Vaccines
* Says in aggregate, VBI stockholders will receive approximately 541.6 million
common shares of SciVac
* Says jeff Baxter will be the president and chief executive officer of the
combined company
* At effective time of merger, each share of VBI will be converted into right
to receive 20.81 common shares of SciVac
* Boards of directors of both companies have unanimously approved agreement
* OPKO Health will be largest shareholder of combined co, with about 14% of the
issued and outstanding shares of combined company
* Holders of vbi's securities will receive shares, options and warrants of
SciVac representing about 46% of combined company
* Source text for Eikon ID:nCCN7tbtMk
* Further company coverage VAC.TO